glp-1 receptor agonist agent A Closer Look at the Dermatological Profile of Agonists GLP1 Receptor Agonists—Effects beyond Obesity

Choi JG, Winn AN, Skandari MR, et al

[DOI] [PubMed] [Google Scholar] 872.Mabilleau G., Mieczkowska A., Chappard D

Anti-proliferative activity of glucagon-like peptide-1 receptor agonist on obesity-associated breast cancer: the impact on modulating adipokines expression in adipocytes and cancer cells

Results We included 39 pwIIH (mean age 33.6 years [SD 8.0], 92.3% female, median BMI 36.3 kg/m 2 [IQR 31.438.3]), with 13 patients being treated with GLP-1-RAs

This effect can be specifically blocked by the GLP-1R antagonist exendin (939) amide

3 There are also strict guidelines for who qualifies for these medications, and theres a spectrum of little-talked-about weight-loss medications available on the market that arent GLP-1s